|
Kyung Dong Pharmaceutical Company Ltd - Company Profile Snapshot
| Company Profile: |
Kyung Dong Pharmaceutical Company Ltd |
| Ticker: |
011040 |
| Exchanges: |
SEO |
| 2008 Sales: |
81,300,000,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Diversified Drugs, Cosmetics, & Health Care |
| Country: |
KOREA (SOUTH) |
| Employees: |
361 |
Business Description
Kyung Dong Pharmaceutical Company Ltd. The Company's principal activities are manufacturing and selling of pharmaceutical products for multiple therapeutic fields. The Company's two main product groups include finished compounds, including acetaminophen, roxithromycin, acyclovir, ofloxacin, dihydroergocristine methanesulfonate, metformin, levosulpiride, dihydroxyaluminum allantoinate, domperidone maleate, ambroxol and other products, and raw bulk materials, comprised of difemerine hydrochloride, tiropramide hydrochloride, cilostazol, aceclofenac, levofloxacin, nizatidine and rebamipide. In addition, the Company is engaged in the sale of animal drugs and sports related products, among others. Kyungdong Pharmaceutical's products are exported to international customers in Brazil, Cambodia, Chile, Colombia, Costa Rica, India, Japan, Jordan, Pakistan, the Republic of Yemen, Spain, Sudan, Syria and Vietnam.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
